PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan New Product Innovation Award Commends Phenofarm® for its Phenolea® Complex - Phenolea® Complex meets the demand for superior, natural antioxidant ingredients -
Frost & Sullivan New Product Innovation Award Commends Phenofarm® for its Phenolea® Complex


NewswireToday - /newswire/ - London, United Kingdom, 2012/09/26 - Phenolea® Complex meets the demand for superior, natural antioxidant ingredients -

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Based on its recent analysis of the antioxidants market, Frost & Sullivan recognizes Phenofarm® with the 2012 Europe New Product Innovation Award for its highly innovative Phenolea® Complex. The product is set to address the European demand for superior, natural antioxidant ingredients.

Phenolea® Complex is derived from olive fruits and is a standardized extract containing molecules which have a high antioxidant capacity. The product is clean label, containing water soluble molecules and is applicable to many food and beverages.

"This novel natural antioxidant ingredient transfers all the perceived advantages of a Mediterranean diet directly to the food products in which it is used," noted Frost & Sullivan Research Analyst Dr. Kaushik Ramakrishnan Shankar. "It is E-number free and manufactured using a sustainable process."

The raw material is olive pulp which is in abundant supply in Italy. The local source of olives provides IP protection for Phenolea® Complex, while strict control of the supply chain ensures that there are no demand-supply gaps for the raw material. At the same time, the vegetable source of the antioxidant is an added advantage for food manufacturers who would like to create both vegetarian and vegan formulations.Phenofarm’s success lies in developing an eco-friendly process based on membrane technology. This process does not use solvents, therefore removing the problems of both solvent handling and residues in the final product.

"Membrane technologies are considered state-of-the-art in food ingredient manufacture, and provides advantages of reducing both energy and water consumption," explained Dr. Shankar. "These advantages are passed onto customers who can create superior formulations with a natural antioxidant."

The product is traceable with an ISO 22005/2007 certification. In comparison to other products like ascorbic acid and rosemary extracts, Phenolea® Complex is superior in preventive oxidative rancidity in several food products.

"Phenofarm’s technological expertise and long-standing domain knowledge have helped customers to create their own unique products," concluded Dr. Shankar. "In addition, local sourcing of raw material and cost-effective processing techniques make the final product highly cost-effective for food manufacturers."

Frost & Sullivan presents this award to the company that has demonstrated excellence in developing a product with innovative elements that leverages leading edge technologies, that offers valued added features and benefits, supports increased customer ROI and has the potential for enhanced customer acquisition/penetration.

Frost & Sullivan Best Practices awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.

About Phenofarm®
Phenofarm® ( is an Italian company active in the production of standardized natural extracts, rich in antioxidant compounds, concentrated into liquids and dry extracts ideal for most formulations. These are natural and innovative products, extracted from fresh edible olives by-products produced by the adjacent oil milling plant.

Phenofarm® production facility is designed to produce large volumes with a patented process which allows the production of Phenolea® Complex, a cost-effective antioxidant, counting on a locally large availability of raw material and a consolidated know-how.

Phenolea® Complex is a new natural antioxidant ingredient which provides protection for food products and for health benefits enhance.

This E-number free new ingredient, manufactured using a sustainable process, is set to address the increasing demand for natural ingredients as an alternative to other natural and synthetic products.
Phenolea® extracts are available in several standardized grades of antioxidant activity.

Phenofarm® products are sourced from locally olive cultivation, in Sabina Valley, Italy, fully traced (Certification ISO 22005:2007).
Manufacturer certified ISO 9001:2008
Products certified ISO 22005:2007

About Frost & Sullivan
Frost & Sullivan (, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us: Start the discussion | Join Us: Join our community | Subscribe: Newsletter on "the next big thing" | Register: Gain access to visionary innovation.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Written by / Agency / Source: Frost & Sullivan


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick Newswire Today Visibility Checker


Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

# # #

  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!

Frost & Sullivan New Product Innovation Award Commends Phenofarm® for its Phenolea® Complex

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan | Phenofarm
Publisher Contact: Emily Bailey 
+44(0)20 7915 7869 emily.bailey[.]
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Articles From Frost & Sullivan / Company Profile

Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application
Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy
Greenphire Continues Commitment to Clinical Research Site Sustainability and Innovation at Global Site Solutions Summit
Frost & Sullivan Highlights argenx for Enhancing the Therapeutic Qualities of Human Antibodies with its Proprietary Antibody Discovery Platform, SIMPL
FDA Grants Breakthrough Therapy Designation for Genentech’s Actemra® (Tocilizumab) in Giant Cell Arteritis, a Form of Vasculitis
MDxHealth Announces Agreement with SouthGenetics for Distribution of SelectMDx in Central/South America
BD and Apax Partners Announce Closing of Joint Venture to Launch Global Respiratory Business
Exosome Diagnostics Enters Agreement with Amgen
Sartorius Stedim Biotech Launches Two Single-use Sartocon® Loop Assemblies with Integrated Polyethersulfone (PESU) Membrane
BD Expands Efforts to Combat Antimicrobial Resistance with New Automated ID/AST System

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business


Visit  Intrinsic Executive Search Ltd

Visit  NAKIVO, Inc.

  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (